| Literature DB >> 32117919 |
Yongqiang Xing1,2, Wuritu Yang3, Guoqing Liu1,2, Xiangjun Cui1,2, Hu Meng1,2, Hongyu Zhao1,2, Xiujuan Zhao1,2, Jun Li1,2, Zhe Liu1, Michael Q Zhang4, Lu Cai1,2.
Abstract
The mechanism of alternative pre-mRNA splicing (AS) during preimplantation development is largely unknown. In order to capture the dynamic changes of AS occurring during embryogenesis, we carried out bioinformatics analysis based on scRNA-seq data over the time-course preimplantation development in mouse. We detected numerous previously-unreported differentially expressed genes at specific developmental stages and investigated the nature of AS at both minor and major zygotic genome activation (ZGA). The AS and differential AS atlas over preimplantation development were established. The differentially alternatively spliced genes (DASGs) are likely to be key splicing factors (SFs) during preimplantation development. We also demonstrated that there is a regulatory cascade of AS events in which some key SFs are regulated by differentially AS of their own gene transcripts. Moreover, 212 isoform switches (ISs) during preimplantation development were detected, which may be critical for decoding the mechanism of early embryogenesis. Importantly, we uncovered that zygotic AS activation (ZASA) is in conformity with ZGA and revealed that AS is coupled with transcription during preimplantation development. Our results may provide a deeper insight into the regulation of early embryogenesis.Entities:
Keywords: alternative splicing; gene expression; preimplantation development; splicing factors; zygotic gene activation
Year: 2020 PMID: 32117919 PMCID: PMC7019016 DOI: 10.3389/fbioe.2020.00035
Source DB: PubMed Journal: Front Bioeng Biotechnol ISSN: 2296-4185
Figure 1A schematic description of dataset, DEGs and DAS. (A,B) is the frequency distribution of reads mapped to protein-coding genes and protein-coding genes captured at every preimplantation development stage. The white circle denotes median of all values. Black rectangle denotes interquartile range (quartile to third quartile). (C) Cell type assignment using the most variable genes across all preimplatation development stages following t-SNE-based visualization of 21 cells. Cells that marked with same color were clustered at the same developmental stage. (D) The number of DEG and DASGs at all preimplantation development stages. The blue denotes DEGs and the red denotes DASGs. (E) The number of DEGs, DASGs and DASG-ISs for every consecutive stages of preimplantation development. DASGs represent genes in which DAS was identified. DAS-ISs represent isoform switches identified from DASGs.
Figure 2The distribution of DE genes. (A) The expression atlas of significantly up-regulated genes in different preimplantation development stages. The gene expression level was normalized by Seurat (see Materials and Methods). (B–D) The intersection between DE genes (B: zygote/oocyte, C: 2-cell/oocyte, D: 4-cell/oocyte) and maternal/zygotic genes. The maternal and zygotic gene sets were derived from Fan et al. (2015). (E) The distribution of DE genes overlapped with maternal and zygotic genes. Zygotic genes marked with red color denotes the up-regulated genes overlapped with zygotic genes from Fan et al. (2015). Maternal genes marked with black color denotes the down-regulated genes overlapped with maternal genes from Fan et al. (2015).
The number of AS events for different developmental stages.
| GTF | 6,335 | 7,089 | 13,945 | 3,059 | 1,203 | 23,054 | 3,912 | 58,597/11,462 |
| Oocyte | 2,965 | 3,506 | 7,701 | 1,491 | 394 | 6,910 | 1,129 | 24,096/6,741 |
| Zygote | 3,098 | 3,684 | 7,876 | 1,545 | 410 | 7,221 | 1,174 | 25,008/6,875 |
| 2-cell | 3,276 | 3,905 | 8,099 | 1,698 | 409 | 7,387 | 1,211 | 25,985/7,147 |
| 4-cell | 3,089 | 3,636 | 7,426 | 1,662 | 360 | 6,574 | 1,111 | 23,858/6,659 |
| 8-cell | 3,074 | 3,663 | 7,196 | 1,722 | 326 | 6,003 | 1,004 | 22,988/6,624 |
| Morula | 3,269 | 3,835 | 7,486 | 1,806 | 368 | 6,619 | 1,101 | 24,484/6,780 |
| Blastocyst | 3,599 | 4,160 | 8,217 | 1,973 | 413 | 7,613 | 1,224 | 27,199/7,311 |
The number after “/” in Sum column denotes the gene number involved with AS.
The length characteristic of alternative region of AS.
| Oocyte | 0.3838 | 0.3295 | 0.2867 | 0.5000 | 0.2496 | 0.2504 | 0.4951 | 0.2497 | 0.2552 | 0.3387 | 0.3508 | 0.3105 |
| Zygote | 0.3838 | 0.3254 | 0.2908 | 0.4891 | 0.2638 | 0.2470 | 0.4892 | 0.2541 | 0.2567 | 0.3366 | 0.3476 | 0.3159 |
| 2-cell | 0.3846 | 0.3291 | 0.2863 | 0.4891 | 0.2671 | 0.2438 | 0.4843 | 0.2532 | 0.2625 | 0.3345 | 0.3321 | 0.3333 |
| 4-cell | 0.3784 | 0.3305 | 0.2910 | 0.4860 | 0.2690 | 0.2451 | 0.4760 | 0.2586 | 0.2654 | 0.3273 | 0.3454 | 0.3273 |
| 8-cell | 0.3709 | 0.3390 | 0.2902 | 0.4767 | 0.2722 | 0.2512 | 0.4722 | 0.2639 | 0.2639 | 0.3275 | 0.3444 | 0.3281 |
| Morula | 0.3741 | 0.3334 | 0.2924 | 0.4746 | 0.2751 | 0.2503 | 0.4698 | 0.2634 | 0.2668 | 0.3300 | 0.3439 | 0.3261 |
| Blastocyst | 0.3682 | 0.3331 | 0.2987 | 0.4748 | 0.2779 | 0.2474 | 0.4737 | 0.2613 | 0.2651 | 0.3300 | 0.3431 | 0.3269 |
| DAS | 0.3743 | 0.3073 | 0.3184 | 0.5120 | 0.2771 | 0.2108 | 0.4825 | 0.2558 | 0.2616 | 0.2200 | 0.4000 | |
%3 = 0, %3 = 1 and %3 = 2 denote that the length of alternative region of AS equals (3n) bp, (3n + 1) bp, and (3n + 2) bp, respectively. The value in every cell denotes the percentage.
Figure 3The functional analysis of genes occurring DAS. (A) GO enrichment analysis of a conserved gene dataset occurring AS during preimplantation development. (B) The network of the enriched GO-BP terms for DASGs between zygote and 2-cell stage.
The number of DAS and DASGs.
| Oocyte | 0 | 380/311 | 426/350 | 392/326 | 479/382 | 565/449 | |
| Zygote | 0 | 365/291 | 342/283 | 382/318 | 461/376 | ||
| 2-cell | 0 | 218/192 | 247/208 | 422/344 | |||
| 4-cell | 0 | 126/113 | 310/259 | ||||
| 8-cell | 0 | 261/210 | |||||
| Morula | 0 | ||||||
| Blastocyst | 0 |
Cutoff: p-value ≤ 0.05 and dPSI ≥ 0.1. Bold digits is corresponding to the seven consecutive development stages.
Figure 4(A) Venn diagram of SF, DE and DASGs across seven consecutive stages of preimplantation development. SF denotes 446 splicing factors. DE denotes 4,947 DE genes in consecutive development stage. For example, DAS denotes 836 genes undergoing DAS in consecutive development stage. (B,C) Number of SFs at every consecutive stage of preimplantation development. SF represents 39 SFs undergoing DAS across seven consecutive stages of preimplantation development. For example, DAS: Occyte_Zygote denotes these genes undergoing DAS from occyte to zygote stages.
Figure 5The hierarchical clustering of preimplantation development stages based on specific SFs.
Figure 6AS read coverage of SRSF3. The x-axis and y-axis denotes genomic coordinate and transcript expression level (RPKM), respectively. The black rectangle and line represent exon and intron, respectively.
Figure 7Expression profiles of DASGs. (A–D) Represent the gene and transcript expression profiles of Supt6, Adar, Upf2 and Cnot6, respectively. The y-axis denotes TPM (Transcripts Per Kilobase Million). The symbol ⊗ denotes switch point. The red line denotes gene expression level and other color lines denote transcript expression level.